A policy and commissioning regime for the clinical assessment, diagnosis and treatment of ADHD in England, sitting on ICB commissioning duties under the NHS Act 2006 and CQC-regulated provider standards under the 2014 Regulated Activities Regulations, and currently being scrutinised through NHS England's ADHD Taskforce and an independent ministerial review.
NHS England estimated up to 316,000 children were waiting for an ADHD assessment in March 2025, with up to 85,000 already waiting longer than two years, and the independent ADHD Taskforce put the cost of untreated ADHD at around £17bn to the UK economy — making this both a major access-failure regime and a fiscal-policy question about ICB capacity, tariffs and Right to Choose.
The ADHD Taskforce delivered its final report on 6 November 2025 and the Department is 'carefully considering its recommendations'; the wider Independent Review into Mental Health Conditions, ADHD and Autism published an interim report on 31 March 2026 and is still running, with the next phase examining service quality, capacity and tariffs.
Prescribes the additional persons for whom an ICB has responsibility under ss.3 and 3A of the NHS Act 2006 — the statutory basis on which ICBs commission ADHD assessment and treatment for their resident populations.
Pair to S.I. 2022/635: defines exceptions to ICB core responsibility under s.14Z31 NHS Act 2006, relevant to the boundary between ICB-commissioned and NHS England-commissioned ADHD services.
Removes the expiry date from the 2014 Regulated Activities Regulations and resets the statutory review cycle to 5 years from 13 July 2023 — keeps the CQC regulatory framework that governs ADHD assessment providers in force indefinitely.
Amends Schedule 1 of the 2014 Regulated Activities Regulations to bring sports and cultural-event treatment within CQC regulation from 7 September 2026 / 6 December 2027. Not ADHD-specific but illustrates the live amendment activity on the CQC-regulated-activity framework that ADHD providers sit within.
Written answer (3 February 2026) confirms publication date of NHS England's independent ADHD Taskforce final report and that DHSC is 'carefully considering its recommendations'.
Committee report citing the NHS England estimate that up to 316,000 children were waiting for an ADHD assessment as of March 2025, with up to 85,000 waiting more than two years.
Earlier committee output citing the independent ADHD Taskforce estimate that the cost of not treating ADHD is around £17 billion to the UK economy.
The Committee's inquiry landing page; frames demand for autism and ADHD assessments and underpins the October 2025 report.
Westminster Hall petitions debate establishing the cross-party framing that 'people are waiting years for an ADHD diagnosis' and that access is limited and inconsistent across the UK.
Records that NHS England published management information on ADHD waits at national level for the first time on 29 May 2025 as part of its ADHD data improvement plan — the data architecture that subsequently underpins the 316,000-children figure.
Independent scrutiny report by the Children's Commissioner examining waiting times and capacity for ADHD and autism assessment in children's services.
Written evidence stating the adult ADHD waiting list has reached up to eight years in some parts of the UK; key practitioner-side evidence into the HSC Committee inquiry.
Written evidence noting the ADHD Taskforce was announced by NHS England in March 2024 but paused at the calling of the general election; argues the Taskforce should be the vehicle for capacity reform.
DHSC consultation document on extending the 2014 Regulated Activities Regulations — statutory basis for the CQC regulatory framework that captures ADHD assessment providers.
Government response to the November 2021 consultation, which preceded the 2025 amending regulations that removed the expiry date.
Parliamentary petition calling for review of ICBs using Indicative Activity Plans as hard caps on ADHD and autism Right to Choose referrals — frames the tariff/cap dispute that runs through the 2025-26 PQ series.
The interim report of the ministerial-commissioned independent review; finds 'substantial pressure on services providing ADHD assessment' and commits the next phase to examining service quality, capacity and tariffs. This is the central live policy-review document on the thread.
Government publication page for the independent review's interim report — outlines progress on the review into the prevalence and support for mental health conditions, ADHD and autism.
Given the extra funding we are providing this year to address long waiting times, we do not consider that a separate emergency fund for autism and ADHD assessments is justified.
Why linked: Frames the pre-2024 Government position rejecting a ring-fenced fund — the policy baseline the current independent review is being measured against.
The final report was published on 6 November 2025, and we are carefully considering its recommendations.
Why linked: Current Government's stated position on the central NHS England Taskforce output — formally a holding line pending the wider independent review.
Why linked: S.I. 2026/495 amends Schedule 1 of the 2014 Regulated Activities Regulations, evidence that the regulated-activity perimeter under which ADHD providers operate continues to be actively maintained by the Department.
These Regulations amend the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 (“the 2014 Regulations”).
Why linked: S.I. 2025/232 removed the expiry date from the 2014 Regulated Activities Regulations — the CQC framework governing ADHD assessment and treatment providers — and reset the statutory review cycle to five-yearly from 13 July 2023.
These Regulations amend the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 (“the 2014 Regulations”).
Why linked: Petitions Committee debate on ADHD assessments and access to services and treatment; core policy scrutiny on NHS provision and access standards
People are waiting years for an ADHD diagnosis, as access to services and treatment in the UK is limited and inconsistent.
Why linked: ICB Exceptions to Core Responsibility Regulations 2022—establishes commissioning governance framework relevant to neurodevelopmental service commissioning
Section 14Z31 of the National Health Service Act 2006 (c. 41) (“the NHS Act 2006”) provides that NHS England must, from time to time, publish rules for determining the group of people for whom an integrated care board has core …
Why linked: ICB Responsibilities Regulations 2022; establishes statutory framework for ICB commissioning of neurodevelopmental services including ADHD assessment
These Regulations prescribe additional persons for whom an Integrated Care Board (“ICB”) has responsibility to arrange for the provision of certain services under the National Health Service Act 2006 (c. 41) (“the NHS Act 2006”). These Regulations also impose the …
Why linked: ICB Nomination Regulations 2022—foundational to ICB structure and commissioning powers referenced in scope for neurodevelopmental guidance
The National Health Service Act 2006 (“the NHS Act 2006”), provides for the establishment of integrated care boards (“ICBs”) to take over the commissioning functions of clinical commissioning groups.
Loading new-since list…
Loading External Lens…
ADHD assessment and treatment in England now sits at the intersection of a statutory commissioning regime under the NHS Act 2006 and S.I. 2022/635, a CQC provider-regulation framework under the Health and Social Care Act 2008 and the 2014 Regulated Activities Regulations, and two live policy reviews. NHS England's independent ADHD Taskforce reported on 6 November 2025 and DHSC is 'carefully considering its recommendations' 1. The wider ministerial Independent Review into Mental Health Conditions, ADHD and Autism published an interim report on 31 March 2026 finding 'substantial pressure on services providing ADHD assessment' 2. The Health and Social Care Committee's October 2025 report placed NHS England's 316,000-children waiting-list figure (with up to 85,000 waiting more than two years) on the parliamentary record 3. The political contest sits on Right to Choose: petitioners argue ICBs are using Indicative Activity Plans as hard caps and NHS Payment Scheme guide prices as a back-door rationing mechanism 4.
The statutory commissioning architecture is settled. ICBs are the commissioners under NHS Act 2006 ss.3 and 3A, with their responsibilities prescribed by the National Health Service (Integrated Care Boards: Responsibilities) Regulations 2022 (S.I. 2022/635) 1 and the exceptions defined by S.I. 2022/736 2. The provider-side framework — the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 — was reset in 2025: S.I. 2025/232 removed the expiry date and put the next statutory review in July 2028, then a five-year cycle thereafter. S.I. 2026/495 has since amended Schedule 1 (sports and cultural-event treatment) with staged commencement on 7 September 2026 and 6 December 2027 — not ADHD-specific, but evidence the Department is actively maintaining the regulated-activity perimeter that ADHD providers sit within. The policy-review machinery is what is actually moving. NHS England's ADHD Taskforce delivered its final report on 6 November 2025 3 and the wider Independent Review's interim report landed on 31 March 2026 4. NHS England has, since 29 May 2025, published national management information on ADHD waits for the first time, under its ADHD data improvement plan 5 — the dataset that produced the Committee's 316,000-children figure 6.
The most material recent developments are evidential rather than legislative. The Independent Review's interim report (31 March 2026) confirmed 'substantial pressure on services providing ADHD assessment' and committed the next phase to closer work on service quality and capacity 1. The Health and Social Care Committee's October 2025 report formalised NHS England's estimate that up to 316,000 children were waiting for an ADHD assessment as of March 2025, with up to 85,000 already waiting more than two years, and recorded the independent Taskforce's £17bn cost-of-not-treating figure 23. A May 2026 PQ asked DHSC what guidance had been issued to NHS bodies on the 'clinical, functional and other criteria' to be used when prioritising ADHD assessments 4 — the first PQ in the series that probes triage rules rather than waiting lists in aggregate. A January 2026 Lords PQ (HL13326) challenged the consultation basis of NHS Payment Scheme guide prices for autism and ADHD services 5, extending the tariff-design line of scrutiny opened by the 2025/26 Payment Scheme PQ cluster 678.
Three things, in priority order. First, the Government response to the ADHD Taskforce final report. As of 3 February 2026 the line was 'carefully considering its recommendations' 1; the longer that holding line runs, the more it shifts substantive accountability onto the Independent Review's final report instead. Second, the final report of the Independent Review into Mental Health Conditions, ADHD and Autism. The interim report committed the next phase to service quality, capacity and (by implication) tariff design 2 — if the final report recommends a national service specification or a waiting-time standard for ADHD assessment, that translates into NHS England guidance and potentially statutory change. Third, the Right to Choose / IAP / tariff dispute. Petition 752706 (May 2025) explicitly asks for review of ICBs using Indicative Activity Plans as hard caps on ADHD and autism Right to Choose referrals 3; the PQ stream now reaches into both ICB prioritisation criteria 4 and the NHS Payment Scheme guide-price consultation process 5. The legal question — whether IAPs as hard caps on Right to Choose are consistent with the ICB's NHS Act 2006 s.3 duty — has not yet been adjudicated in the events list. Also worth watching: the next statutory review of the 2014 Regulated Activities Regulations, now due 13 July 2028 under the cycle reset by S.I. 2025/232, which is the natural vehicle for any CQC-side reform on ADHD provider standards.
Inferred from corpus gap: the ADHD Taskforce final report itself (6 November 2025) is not retrieved as a foundational document in this build; only the ministerial publication date and the holding line are evidenced 1. The substance of its recommendations therefore cannot be cited with confidence here. Inferred from corpus gap: no Government formal response to the October 2025 Health and Social Care Committee report has been retrieved 2. Inferred from corpus gap: no published equality impact assessment of NHS Payment Scheme guide-price changes on ADHD service availability has been retrieved, despite repeated PQs asking for one 345. A live uncertainty is whether ICB use of Indicative Activity Plans as hard caps on Right to Choose ADHD referrals would survive judicial review on the s.3 duty point — petitioners assert it would not 6; no court has so ruled in the events list.
This briefing covers ADHD assessment and treatment as an NHS clinical regime in England. Educational support and school-based ADHD accommodations are out of scope (the DfE PQ at is on adjacent territory, not ADHD treatment policy). Medication licensing and pharmacovigilance (MHRA remit) are out of scope unless directly tied to NHS access policy. The Mental Health Act 2025 reform programme (Keeling schedules at ) is statutorily adjacent — it amends the Mental Health Act 1983 framework for compulsory detention and after-care, not ADHD treatment, and is only retrieved here because the 2026 ADHD review sits inside the wider 'Mental Health Conditions, ADHD and Autism' brief. Autism-specific policy appears here only where the events explicitly couple ADHD and autism
Bills and Acts this regime substantively depends on. Links go to the bill's own thread on this site (where available) and to bills.parliament.uk.
Confers ss.3 and 3A commissioning duties on Integrated Care Boards as prescribed by S.I. 2022/635 — the statutory basis for ICB-commissioned ADHD assessment and treatment.
Confers powers under ss.8, 20 and 161 to specify regulated activities and fundamental standards; provides the statutory basis for CQC registration and inspection of NHS and independent-sector ADHD providers via the 2014 Regulated Activities Regulations.
Established Integrated Care Boards (replacing CCGs) and amended s.20 of the 2008 Act — restructured both the commissioning side and the regulated-activity side of the ADHD regime.
ADHD assessment and treatment in England sits on three load-bearing statutory layers, plus a softer policy-review overlay.
First, the commissioning layer. NHS Act 2006 ss.3 and 3A (with s.14Z31) tell each ICB which population it must commission for. The detail of who counts as an ICB's responsibility — and therefore whose ADHD assessment the ICB has to arrange — is set out in S.I. 2022/635 (with S.I. 2022/736 carving out NHS England-commissioned exceptions). That is the lever the PQ stream is actually attacking when it asks why ICBs are deprioritising ADHD or using Indicative Activity Plans as hard caps on Right to Choose referrals: the duty is statutory, but the manner of discharge — caps, prioritisation criteria, tariff acceptance — is operational.
Second, the provider-regulation layer. Whoever delivers the assessment — an NHS trust, an independent provider under Right to Choose, or a private clinic — is doing 'treatment of disease, disorder or injury' under Schedule 1 of the 2014 Regulated Activities Regulations and so must be registered with the CQC under Part 1 of the Health and Social Care Act 2008. S.I. 2025/232 removed the 2014 Regulations' expiry date and re-set the statutory review clock, so this CQC framework is now indefinite. S.I. 2026/495 confirms the Department is actively maintaining Schedule 1 (bringing sports and cultural-event treatment within the regulated-activity perimeter) — not ADHD-specific, but evidence that the regulatory perimeter remains live.
Third, the tariff and Payment Scheme layer. The NHS Payment Scheme guide prices for autism and ADHD services govern what providers are paid, which in turn governs supply. The 2025-26 PQ series (37041, 37042, 37792, 34829, HL13326) frames this as the binding constraint: Right to Choose only works if guide prices and ICB IAPs let providers operate at scale. There is no separate statutory instrument doing the tariff work; the Payment Scheme is an administrative product of NHS England's pricing functions under the NHS Act 2006.
Fourth, the policy-review overlay. The ADHD Taskforce (final report 6 November 2025) and the Independent Review into Mental Health Conditions, ADHD and Autism (interim report 31 March 2026) are not statutory; they are ministerial / NHSE-commissioned exercises that produce recommendations for action inside the three statutory layers above. Their output — particularly on prioritisation criteria, tariff design and service specification — is what would translate into regulatory change.
The regime cannot, by itself, set a national waiting-time standard for ADHD assessment: there is no constitutional or statutory standard for neurodevelopmental assessment equivalent to the 18-week RTT standard for physical-health pathways, which is why every constituency-level PQ in this corpus is met with an ICB-level answer.
Patient right to choose any clinically appropriate provider for an NHS-funded ADHD assessment, including independent-sector providers.
An ICB's planning estimate of expected activity volumes with a given provider for a given period.
NHS England programme to publish standardised national management information on ADHD waits, first published 29 May 2025.
NHS England-commissioned independent body announced March 2024, paused at the 2024 general election, and reporting finally on 6 November 2025.
Final report of the Independent Review into Mental Health Conditions, ADHD and Autism (interim report 31 March 2026 committed the next phase to quality and capacity work).
Formal Government response to the ADHD Taskforce final report (published 6 November 2025); as of 3 February 2026 recommendations were under consideration.
On the ADHD Taskforce final report: holding line — recommendations are 'under careful consideration'; no formal response yet published. On the wider regime: commissioning the Independent Review into Mental Health Conditions, ADHD and Autism (interim 31 March 2026) as the vehicle for policy change. Has not committed to a national ADHD waiting-time standard.Feb 2026Mar 2026Apr 2026
Tension with Petitioners — Right to Choose / NHS caps and tariffs, ADHD 360
On the data architecture: published first national management information on ADHD waits on 29 May 2025 under the ADHD data improvement plan, accepting transparency as a precondition for reform. On capacity: sponsored the independent ADHD Taskforce (final report 6 November 2025) but paused it at the 2024 general election, delaying recommendations by over a year.Jun 2025Feb 2026Jan 2024
On children's diagnostic pathways: Committee's October 2025 report places NHS England's 316,000-children waiting-list figure (with up to 85,000 waiting more than two years as of March 2025) on the parliamentary record and frames the pathway as in systemic failure.Oct 2025Oct 2025Jun 2025
On capacity: adult ADHD waits have reached up to eight years in some parts of the UK, reflecting a failure of earlier-life intervention; the (then paused) NHS England ADHD Taskforce should be the vehicle for reform. Position aligns with the Right to Choose / tariff-reform line.Jan 2024Jan 2024
Tension with Department of Health and Social Care
On the children's ADHD pathway: October 2024 report identifies waiting times and capacity in ADHD and other neurodevelopmental assessment services as a systemic failure requiring urgent reform.Oct 2024
On Right to Choose: ICBs are using Indicative Activity Plans as hard caps on ADHD and autism Right to Choose referrals, converting a statutory entitlement into a rationing queue; petitioners demand review of caps and of NHS Payment Scheme guide prices that they argue are set below provider sustainability.May 2025
Tension with Department of Health and Social Care, Integrated Care Boards
On commissioning behaviour: PQs identify ICBs as using IAPs as hard caps on Right to Choose ADHD referrals and as deprioritising ADHD against other neurodevelopmental conditions — the operational decisions which Right to Choose petitioners frame as breaching the statutory s.3 duty.Mar 2025May 2025Mar 2026
Tension with Petitioners — Right to Choose / NHS caps and tariffs